March 4 (Reuters) - Telix Pharmaceuticals Ltd ( TLPPF ):

* TELIX TO ACQUIRE ARTMS, INC. AND ITS ADVANCED ISOTOPE

PRODUCTION

PLATFORM

* TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO

BE

FINANCIALLY ACCRETIVE, ADD ADDITIONAL REVENUE

* TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO

HAVE

POSITIVE IMPACT ON GROSS MARGINS FOR ILLUCCIX AND ZIRCAIX (WHEN

COMMERCIALLY AVAILABLE)

* TELIX PHARMACEUTICALS ( TLPPF )- DEAL COMPRISES OF US$42.5 MILLION

UPFRONT

CONSIDERATION PAYABLE IN FORM OF 5.7 MILLION TELIX ORDINARY

SHARES TO BE ISSUED AT CLOSING

Source text for Eikon:

Further company coverage: